SpO2 Data Collection in Pediatric Patients Using INVSENSOR00061
NCT ID: NCT05896267
Last Updated: 2025-11-12
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
64 participants
INTERVENTIONAL
2023-05-15
2023-06-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Validation for SpO2 Function of Masimo INVSENSOR00069
NCT06120777
Convenience Sample Data Collection for INVSENSOR00045
NCT04894669
INVSENSOR00027 Clinical Performance Study
NCT03650192
INVSENSOR00032 and INVSENSOR00033 Respiration Rate Clinical Performance Study
NCT03897179
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation of INVSENSOR00026
NCT03610269
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Masimo INVSENSOR00061
Experimental: INVSENSOR00061 All subjects are enrolled into this arm will have noninvasive blood oxygen measurements obtained.
Masimo INVSENSOR00061
Masimo INVSENSOR00061 will be used to measure noninvasive SpO2 (Oxygen Saturation )
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Masimo INVSENSOR00061
Masimo INVSENSOR00061 will be used to measure noninvasive SpO2 (Oxygen Saturation )
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Subject has a skin condition and/or deformity at the planned application site, which would preclude sensor placement and measurements.
* Subject has an absence or deformities of limbs or severe edema, which would interfere with sensor application or prevent the proper fit of the sensors.
* Subject is not suitable for the investigation at the discretion of the Investigator.
37 Weeks
18 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Masimo Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bailony Pediatrics
National City, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BAIL0003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.